Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MCC Global NV, formerly known as Moore, Clayton & Co., was a publicly traded investment banking and strategic advisory firm that specialized in the life sciences, technology, and media sectors. Headquartered in London and listed on the Frankfurt Stock Exchange, the company provided corporate finance, restructuring, and strategic consulting services to emerging growth companies. MCC Global was particularly active in the biotechnology space, where it assisted firms with capital raising, cross-border partnerships, and operational turnarounds. The company ceased major operations following financial difficulties and was eventually delisted and liquidated.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MCC Global.